Back to Diagnostics & Biomarkers
Diagnostics & Biomarkers

Kidney ValuesEvidence & Dosage

Kreatinin, Harnstoff, eGFR, Cystatin C — Nierenfunktion bewerten.

Evidence at a glance

Total studies
273
With abstract
50
Meta / Systematic / RCT
0
Highly cited
50
Publication years
1997–2026

Kidney Values in the context of Diagnostics & Biomarkers

This topic is part of our "Diagnostics & Biomarkers" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Diagnostics & Biomarkers

Top studies on Kidney Values

Ranked by influential-citation count (Semantic Scholar) and publication year.

  1. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.

    Kidney international2012n=100200 influential citations

    Acute kidney injury may increase the risk for chronic kidney disease and end-stage renal disease. In an attempt to summarize the literature and provide more compelling evidence, we conducted a systematic review comparing the risk for CKD,…

  2. Chronic kidney disease and mortality risk: a systematic review.

    Journal of the American Society of Nephrology : JASN2006200 influential citations

    Current guidelines identify people with chronic kidney disease (CKD) as being at high risk for cardiovascular and all-cause mortality. Because as many as 19 million Americans may have CKD, a comprehensive summary of this risk would be…

  3. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

    Journal of the American Society of Nephrology : JASN2004n=22,634200 influential citations

    Chronic kidney disease (CKD) is a major public health problem. Conflicting evidence exists among community-based studies as to whether CKD is an independent risk factor for adverse cardiovascular outcomes. After subjects with a baseline…

  4. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

    Critical care (London, England)2013n=744200 influential citations

    <h4>Introduction</h4>Acute kidney injury (AKI) can evolve quickly and clinical measures of function often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying early markers of kidney damage has been…

  5. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

    JAMA2011n=3,879200 influential citations

    <h4>Context</h4>A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes…

  6. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

    JAMA2012n=1,000200 influential citations

    <h4>Context</h4>The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation more accurately estimates glomerular filtration rate (GFR) than the Modification of Diet in Renal Disease (MDRD) Study equation using the same…

  7. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

    Kidney international2011200 influential citations

    Screening for chronic kidney disease is recommended in people at high risk, but data on the independent and combined associations of estimated glomerular filtration rate (eGFR) and albuminuria with all-cause and cardiovascular mortality…

  8. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

    Kidney international2011n=11,144200 influential citations

    Both a low estimated glomerular filtration rate (eGFR) and albuminuria are known risk factors for end-stage renal disease (ESRD). To determine their joint contribution to ESRD and other kidney outcomes, we performed a meta-analysis of nine…

  9. Prevalence of chronic kidney disease in population-based studies: systematic review.

    BMC public health2008n=65,181200 influential citations

    <h4>Background</h4>Chronic kidney disease (CKD) is becoming a major public health problem worldwide. This article reviews the published evidence of prevalence of CKD in population-based study samples that used the standardized definition…

  10. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

    American journal of kidney diseases : the official journal of the National Kidney Foundation2013200 influential citations

    In response to the recently released 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury (AKI), the National Kidney Foundation organized a group of US experts in adult and pediatric…

More topics in Diagnostics & Biomarkers

Blood Glucose

Nüchtern, postprandial, Glukoseschwankungen — Grundlage für metabolische Gesundheit.

Blood Pressure Tracking

Häusliche Messung, 24h-Messung, Weißkittelhypertonie.

Body Temperature Tracking

Basaltemperatur, Zyklus, Krankheit, Schlafphasen via Wearable.

Complete Blood Count

Kleines/großes Blutbild, Erythrozyten, Leukozyten, Thrombozyten — Standardpanel.

Continuous Glucose Monitor

Echtzeit-Blutzucker via Sensor — Lernkurve und Limitationen.

Cycle Tracking

Menstruationszyklus, Symptome, Fertilität — Apps und Wearables.

Fasting Insulin & HOMA-IR

Insulinresistenz früh erkennen — wichtiger als HbA1c bei Risiko-Patienten.

Geroscience Biomarkers

Automatisch via Trend Scout entdeckt. Aging biomarkers and biological clocks are central to longevity interventions and geroscience research.. PubMed: 479 Ergebnisse.

HbA1c

3-Monats-Mittel des Blutzuckers, diabetisches Risiko, Longevity-Marker.

Homocysteine

Methylierungs-Marker, kardiovaskuläres und neurologisches Risiko.

HRV Tracking

Herzratenvariabilität als Resilienz- und Erholungs-Indikator.

Inflammation Markers

hs-CRP, IL-6, Fibrinogen — chronische niedriggradige Entzündung als Risikofaktor.

Lipid Profile

LDL-C, HDL, Triglyceride, ApoB — moderne kardiovaskuläre Risiko-Bewertung.

Liver Values

ALT, AST, GGT, Bilirubin — was hohe Werte bedeuten und wann sie ein Problem sind.

Mood Tracking

Daily Mood Logging, Korrelationen mit Schlaf/Bewegung/Ernährung.

Nutrition Tracking

Cronometer, MyFitnessPal, Makros & Mikros, Limitationen.

Resting Heart Rate

Trend-Marker für kardiovaskuläre Fitness und Übertraining.

Thyroid Panel

TSH, fT3, fT4, ggf. reverse T3 und Antikörper — vollständiges Schilddrüsen-Panel.

VO2max

Maximale Sauerstoffaufnahme — stärkster Longevity-Prädiktor.

Wearables

Übersicht: Oura, Whoop, Apple Watch, Garmin, Fitbit — Vor- und Nachteile.

Related topics from other worlds